Abstract
Introduction: Recently, studies have suggested a role of motor symptom asymmetry on impaired emotional recognition abilities in Parkinson’s disease with a greater vulnerability in patients with a predominance of left-sided symptoms. However, none of them explored the interaction between motor symptom asymmetry and dopamine replacement therapy in different stages of the disease. Methodology: We explored the recognition of vocal emotion (i.e., emotional prosody) in 15 newly diagnosed Parkinson’s disease patients in the early stages of the disease, 15 patients in the advanced stages of the disease and 15 healthy controls. The early patients were studied in two conditions: ON and OFF dopaminergic replacement therapy and both Parkinson’s disease groups (early and advanced) were divided into two subgroups according to the asymmetry of motor symptoms. Results: The analyses revealed two patterns of results. First, as predicted, we observed a reduction in performance for the recognition of vocal emotions in patients with a predominance of left-sided symptoms as compared to both healthy controls and predominantly right-sided symptom patients. Second, in the early stages of the disease, we observed a deleterious effect of dopatherapy on the recognition of vocal emotions for the patients with left-predominant symptoms, and the inverse pattern (i.e., a positive effect of dopatherapy) for the patients with right-predominant symptoms. Conclusions: Our results bring to knowledge the differential effects of disease duration, dopaminergic replacement therapy and motor symptom asymmetry on vocal emotion recognition in Parkinson’s disease.
Journal Section:
Research Article
References
1.
Grandjean
D
. Brain networks of emotional prosody processing
. Emot Rev
. 2021
;13
(1
):34
–43
. 2.
Péron
JA
, Frühholz
S
, Vérin
M
, Grandjean
D
. Subthalamic nucleus: a key structure for emotional component synchronization in humans
. Neurosci Biobehav Rev
. 2013
;37
(3
):358
–73
. 3.
Pierce
JE
, Péron
J
. The basal ganglia and the cerebellum in human emotion
. Soc Cogn Affect Neurosci
. 2020
;15
(5
):599
–613
. 4.
Stirnimann
N
, N’Diaye
K
, Jeune
FL
, Houvenaghel
JF
, Robert
G
, Drapier
S
, et al. Hemispheric specialization of the basal ganglia during vocal emotion decoding: evidence from asymmetric Parkinson’s disease and 18FDG PET
. Neuropsychologia
. 2018
;119
:1
–11
. 5.
Benis
D
, Haegelen
C
, Voruz
P
, Pierce
J
, Milesi
V
, Houvenaghel
JF
, et al. Subthalamic nucleus oscillations during vocal emotion processing are dependent of the motor asymmetry of Parkinson’s disease
. Neuroimage
. 2020
;222
:117215
. 6.
Voruz
P
, Le Jeune
F
, Haegelen
C
, N’Diaye
K
, Houvenaghel
JF
, Sauleau
P
, et al. Motor symptom asymmetry in Parkinson’s disease predicts emotional outcome following subthalamic nucleus deep brain stimulation
. Neuropsychologia
. 2020
;144
:107494
. 7.
Garrido-Vásquez
P
, Pell
MD
, Paulmann
S
, Sehm
B
, Kotz
SA
. Impaired neural processing of dynamic faces in left-onset Parkinson’s disease
. Neuropsychologia
. 2016
;82
:123
–33
. 8.
Garrido-Vásquez
P
, Pell
MD
, Paulmann
S
, Strecker
K
, Schwarz
J
, Kotz
SA
. An ERP study of vocal emotion processing in asymmetric Parkinson’s disease
. Soc Cogn Affect Neurosci
. 2013
;8
(8
):918
–27
. 9.
Ventura
MI
, Baynes
K
, Sigvardt
KA
, Unruh
AM
, Acklin
SS
, Kirsch
HE
, et al. Hemispheric asymmetries and prosodic emotion recognition deficits in Parkinson’s disease
. Neuropsychologia
. 2012
;50
(8
):1936
–45
. 10.
Yuvaraj
R
, Murugappan
M
. Hemispheric asymmetry non-linear analysis of EEG during emotional responses from idiopathic Parkinson’s disease patients
. Cogn Neurodyn
. 2016
;10
(3
):225
–34
. 11.
Ck
Y
, M
H
, R
Y
, Ngadiran
R
, H
AA
, Yaacob
S
, et al. Bispectral features and mean shift clustering for stress and emotion recognition from natural speech
. Comput Electr Eng
. 2017
;62
:676
–91
. 12.
Provitera
V
, Nolano
M
, Caporaso
G
, Stancanelli
A
, Mozzillo
S
, Piscosquito
G
, et al. Asymmetric sudomotor impairment in Parkinson disease
. Clin Neurophysiol
. 2019
;130
(1
):e11
. 13.
Kotz
SA
, Kalberlah
C
, Bahlmann
J
, Friederici
AD
, Haynes
JD
. Predicting vocal emotion expressions from the human brain
. Hum Brain Mapp
. 2013
;34
(8
):1971
–81
. 14.
Kotz
SA
, Meyer
M
, Alter
K
, Besson
M
, von Cramon
DY
, Friederici
AD
. On the lateralization of emotional prosody: an event-related functional MR investigation
. Brain Lang
. 2003
;86
(3
):366
–76
. 15.
Clark
US
, Neargarder
S
, Cronin-Golomb
A
. Specific impairments in the recognition of emotional facial expressions in Parkinson’s disease
. Neuropsychologia
. 2008
;46
(9
):2300
–9
. 16.
Clark
US
, Neargarder
S
, Cronin-Golomb
A
. Visual exploration of emotional facial expressions in Parkinson’s disease
. Neuropsychologia
. 2010
;48
(7
):1901
–13
. 17.
Buxton
SL
, MacDonald
L
, Tippett
LJ
. Impaired recognition of prosody and subtle emotional facial expressions in Parkinson’s disease
. Behav Neurosci
. 2013
;127
(2
):193
–203
. 18.
Dan
R
, Růžička
F
, Bezdicek
O
, Roth
J
, Růžička
E
, Vymazal
J
, et al. Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson’s disease
. Eur Neuropsychopharmacol
. 2019
;29
(11
):1258
–72
. 19.
Péron
J
, Grandjean
D
, Drapier
S
, Vérin
M
. Effect of dopamine therapy on nonverbal affect burst recognition in Parkinson’s disease
. PLoS One
. 2014
;9
(3
):e90092
. 20.
Palmeri
R
, Lo Buono
V
, Bonanno
L
, Allone
C
, Drago
N
, Sorbera
C
, et al. Impaired recognition of facial emotion in patients with Parkinson disease under dopamine therapy
. J Geriatr Psychiatry Neurol
. 2020
;33
(5
):265
–71
. 21.
Lawrence
AD
, Goerendt
IK
, Brooks
DJ
. Impaired recognition of facial expressions of anger in Parkinson’s disease patients acutely withdrawn from dopamine replacement therapy
. Neuropsychologia
. 2007
;45
(1
):65
–74
. 22.
Vaillancourt
DE
, Schonfeld
D
, Kwak
Y
, Bohnen
NI
, Seidler
R
. Dopamine overdose hypothesis: evidence and clinical implications
. Mov Disord
. 2013
;28
(14
):1920
–9
. 23.
Hanna-Pladdy
B
, Pahwa
R
, Lyons
KE
. Paradoxical effect of dopamine medication on cognition in Parkinson’s disease: relationship to side of motor onset
. J Int Neuropsychol Soc
. 2015
;21
(4
):259
–70
. 24.
Hoehn
MM
, Yahr
MD
. Parkinsonism: onset, progression, and mortality
. Neurology
. 1967
;17
(5
):427
–42
. 25.
Hughes
AJ
, Daniel
SE
, Kilford
L
, Lees
AJ
. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases
. J Neurol Neurosurg Psychiatry
. 1992
;55
(3
):181
–4
. 26.
Fahn
S
, Elton
R
, Committee
UD
, Park
F
. Unified Parkinson’s disease rating scale
. NJ
: Macmillan Healthcare Information
; 1987
. Vol. 11
. p. 153
–63
.27.
Schwab
J
. Projection technique for evaluating surgery in Parkinson’s disease
. Third symposium on Parkinson’s disease/E & S livingston
; 1969
.28.
Tomlinson
CL
, Stowe
R
, Patel
S
, Rick
C
, Gray
R
, Clarke
CE
. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease
. Mov Disord
. 2010
;25
(15
):2649
–53
. 29.
Constantin
IM
, Voruz
P
, Péron
JA
. Moderating effects of uric acid and sex on cognition and psychiatric symptoms in asymmetric Parkinson’s disease
. Biol Sex Differ
. 2023
;14
(1
):26
–11
. 30.
Voruz
P
, Constantin
IM
, Péron
JA
. Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson’s disease
. Neuropsychologia
. 2022
;177
:108419
. 31.
Voruz
P
, Haegelen
C
, Assal
F
, Drapier
S
, Drapier
D
, Sauleau
P
, et al. Motor symptom asymmetry predicts cognitive and neuropsychiatric profile following deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: a 5-year longitudinal study
. Arch Clin Neuropsychol
. 2023
;38
(6
):904
–12
. 32.
Voruz
P
, Pierce
J
, Ahrweiller
K
, Haegelen
C
, Sauleau
P
, Drapier
S
, et al. Motor symptom asymmetry predicts non-motor outcome and quality of life following STN DBS in Parkinson’s disease
. Sci Rep
. 2022
;12
(1
):3007
. 33.
34.
Matteau
E
, Dupré
N
, Langlois
M
, Jean
L
, Thivierge
S
, Provencher
P
, et al. Mattis dementia rating scale 2: screening for MCI and dementia
. Am J Alzheimers Dis Other Demen
. 2011
;26
(5
):389
–98
. 35.
Nelson
HE
. A modified card sorting test sensitive to frontal lobe defects
. Cortex
. 1976
;12
(4
):313
–24
. 36.
Reitan
RM
. Validity of the Trail Making Test as an indicator of organic brain damage
. Percept Mot Skills
. 1958
;8
(7
):271
–6
. 37.
Cardebat
D
, Doyon
B
, Puel
M
, Goulet
P
, Joanette
Y
. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level
. Acta Neurol Belg
. 1990
;90
(4
):207
–17
.38.
Woods
SP
, Scott
JC
, Sires
DA
, Grant
I
, Heaton
RK
, Tröster
AI
, et al. Action (verb) fluency: test–retest reliability, normative standards, and construct validity
. J Int Neuropsychol Soc
. 2005
;11
(4
):408
–15
. 39.
Stroop
JR
. Studies of interference in serial verbal reactions
. J Exp Psychol
. 1935
;18
(6
):643
–62
. 40.
Montgomery
SA
, Åsberg
M
. A new depression scale designed to be sensitive to change
. Br J Psychiatry
. 1979
;134
(4
):382
–9
. 41.
42.
Péron
J
, Grandjean
D
, Le Jeune
F
, Sauleau
P
, Haegelen
C
, Drapier
D
, et al. Recognition of emotional prosody is altered after subthalamic nucleus deep brain stimulation in Parkinson's disease
. Neuropsychologia
. 2010
;48
(4
):1053
–62
. 43.
Péron
J
, El Tamer
S
, Grandjean
D
, Leray
E
, Travers
D
, Drapier
D
, et al. Major depressive disorder skews the recognition of emotional prosody
. Prog Neuro-Psychopharmacol Biol Psychiatry
. 2011
;35
(4
):987
–96
. 44.
Argaud
S
, Vérin
M
, Sauleau
P
, Grandjean
D
. Facial emotion recognition in Parkinson’s disease: a review and new hypotheses
. Mov Disord
. 2018
;33
(4
):554
–67
. 45.
Mondillon
L
, Mermillod
M
, Musca
SC
, Rieu
I
, Vidal
T
, Chambres
P
, et al. The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson’s disease
. Neuropsychologia
. 2012
;50
(12
):2869
–79
. 46.
Le Jeune
F
, Péron
J
, Grandjean
D
, Drapier
S
, Haegelen
C
, Garin
E
, et al. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study
. Eur J Nucl Med Mol Imaging
. 2010
;37
(8
):1512
–20
. 47.
Harris
E
, McNamara
P
, Durso
R
. Apathy in patients with Parkinson disease as a function of side of onset
. J Geriatr Psychiatry Neurol
. 2013
;26
(2
):95
–104
. 48.
Borghammer
P
. The α-synuclein origin and connectome model (SOC Model) of Parkinson’s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline
. J Parkinsons Dis
. 2021
;11
(2
):455
–74
. 49.
Borghammer
P
, Van Den Berge
N
. Brain-first versus gut-first Parkinson’s disease: a hypothesis
. J Parkinsons Dis
. 2019
;9
(s2
):S281
–95
. 50.
Takahashi
H
, Yahata
N
, Koeda
M
, Takano
A
, Asai
K
, Suhara
T
, et al. Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study
. Neuroimage
. 2005
;27
(4
):991
–1001
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
